Nonoptimal Vaginal Microbiota After Azithromycin Treatment for Chlamydia trachomatis Infection.
Nonoptimal Vaginal Microbiota After Azithromycin Treatment for Chlamydia trachomatis Infection.
复制标题
DOI:
10.1093/infdis/jiz499
复制
发表时间:
2020-02-03
期刊:
影响因子:
--
通讯作者:
Ravel J
中科院分区:
文献类型:
--
作者:
Tamarelle J;Ma B;Gajer P;Humphrys MS;Terplan M;Mark KS;Thiébaut ACM;Forney LJ;Brotman RM;Delarocque-Astagneau E;Bavoil PM;Ravel J
We characterized the composition and structure of the vaginal microbiota in a cohort of 149 women with genital Chlamydia trachomatis infection at baseline who were followed quarterly for 9 months after antibiotic treatment. At time of diagnosis, the vaginal microbiota was dominated by Lactobacillus iners or a diverse array of bacterial vaginosis–associated bacteria including Gardnerella vaginalis. Interestingly, L. iners–dominated communities were most common after azithromycin treatment (1 g monodose), consistent with the observed relative resistance of L. iners to azithromycin. Lactobacillus iners–dominated communities have been associated with increased risk of C. trachomatis infection, suggesting that the impact of antibiotic treatment on the vaginal microbiota could favor reinfections. These results provide support for the dual need to account for the potential perturbing effect(s) of antibiotic treatment on the vaginal microbiota, and to develop strategies to protect and restore optimal vaginal microbiota. Azithromycin treatment used for Chlamydia trachomatis infection appears to have a long-lasting impact on the vaginal microbiota (up to 9 months), favoring L. iners–dominated communities, a known risk factor for C. trachomatis infection, thus fueling an increased susceptibility to reinfection.
登录
查看更多内容
影响因子:
10.5
作者:
Ma B;Forney LJ;Ravel J
通讯作者:
Ravel J
影响因子:
48
作者:
Callahan BJ;McMurdie PJ;Rosen MJ;Han AW;Johnson AJ;Holmes SP
通讯作者:
Holmes SP
DOI:
10.1086/657320
发表时间:
2010-12-15
期刊:
The Journal of infectious diseases
影响因子:
--
作者:
Brotman RM;Klebanoff MA;Nansel TR;Yu KF;Andrews WW;Zhang J;Schwebke JR
通讯作者:
Schwebke JR
DOI:
10.1136/bmj.c1642
发表时间:
2010-04-08
期刊:
BMJ (Clinical research ed.)
影响因子:
--
作者:
Oakeshott P;Kerry S;Aghaizu A;Atherton H;Hay S;Taylor-Robinson D;Simms I;Hay P
通讯作者:
Hay P
影响因子:
17.1
作者:
Gajer P;Brotman RM;Bai G;Sakamoto J;Schütte UM;Zhong X;Koenig SS;Fu L;Ma ZS;Zhou X;Abdo Z;Forney LJ;Ravel J
通讯作者:
Ravel J